APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuromodulation Devices and Implantable Infusion Pumps

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Selected research

Market Outlook & Growth Opportunities

Global Neuromodulation Devices and Implantable Infusion Pumps Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchNeuromodulation Devices and Implantable Infusion Pumps Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuromodulation Devices and Implantable Infusion Pumps Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Neuromodulation Devices and Implantable Infusion Pumps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

Read the full market overview

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.

This report provides an overview of the global Neuromodulation Devices and Implantable Infusion Pumps market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neuromodulation Devices and Implantable Infusion Pumps and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neuromodulation Devices and Implantable Infusion Pumps sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neuromodulation Devices and Implantable Infusion Pumps market size, projected growth trends, production technologies, key applications, and end-use industries.

Neuromodulation Devices and Implantable Infusion Pumps Segment by Company

Medtronic

Boston Scientific Corporation

St. Jude Medical

Synapse Biomedical

Nevro Corporation

Neuropace

Cyberonics

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

Neuromodulation Devices and Implantable Infusion Pumps Segment by Type

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagal Nerve Stimulation

Gastric Stimulation

Transcranial Magnetic Stimulation

Transcutaneous Electrical Stimulation

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Application

Parkinson's Disease

Epilepsy

Pain

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neuromodulation Devices and Implantable Infusion Pumps status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neuromodulation Devices and Implantable Infusion Pumps market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neuromodulation Devices and Implantable Infusion Pumps significant trends, drivers, influence factors in global and regions.

6. To analyze Neuromodulation Devices and Implantable Infusion Pumps competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuromodulation Devices and Implantable Infusion Pumps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuromodulation Devices and Implantable Infusion Pumps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuromodulation Devices and Implantable Infusion Pumps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neuromodulation Devices and Implantable Infusion Pumps market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neuromodulation Devices and Implantable Infusion Pumps industry.

Chapter 3: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neuromodulation Devices and Implantable Infusion Pumps in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neuromodulation Devices and Implantable Infusion Pumps in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neuromodulation Devices and Implantable Infusion Pumps Industry Trends Table 2. Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers Table 3. Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges Table 4. Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Company (2021-2026) Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Company (Unit) & (2021-2026) Table 8. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Company (2021-2026) Table 9. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neuromodulation Devices and Implantable Infusion Pumps Key Company Manufacturing Base & Headquarters Table 12. Global Neuromodulation Devices and Implantable Infusion Pumps Company, Product Type & Application Table 13. Global Neuromodulation Devices and Implantable Infusion Pumps Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neuromodulation Devices and Implantable Infusion Pumps by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Spinal Cord Stimulation Table 18. Significant Companies of Deep Brain Stimulation Table 19. Significant Companies of Sacral Nerve Stimulation Table 20. Significant Companies of Vagal Nerve Stimulation Table 21. Significant Companies of Gastric Stimulation Table 22. Significant Companies of Transcranial Magnetic Stimulation Table 23. Significant Companies of Transcutaneous Electrical Stimulation Table 24. Significant Companies of Other Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type 2021 VS 2025 VS 2032 (Unit) Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2021-2026) & (Unit) Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2027-2032) & (Unit) Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Type (2021-2026) Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Type (2027-2032) Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2021-2026) & (US$ Million) Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2027-2032) & (US$ Million) Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type (2021-2026) Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type (2027-2032) Table 35. Significant Companies of Parkinson's Disease Table 36. Significant Companies of Epilepsy Table 37. Significant Companies of Pain Table 38. Significant Companies of Other Table 39. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application 2021 VS 2025 VS 2032 (Unit) Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2021-2026) & (Unit) Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2027-2032) & (Unit) Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Application (2021-2026) Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Application (2027-2032) Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application (2021-2026) Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application (2027-2032) Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032 (Unit) Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit) Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2026) Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2027-2032) & (Unit) Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2027-2032) Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Region (2021-2026) Table 57. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Region (2027-2032) Table 59. Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (USD/Unit) by Region (2021-2026) Table 60. Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (USD/Unit) by Region (2027-2032) Table 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032 (Unit) Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021-2026) Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2027-2032) Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Market Share by Country (2021-2026) Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Market Share by Country (2027-2032) Table 71. Medtronic Company Information Table 72. Medtronic Business Overview Table 73. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 75. Medtronic Recent Development Table 76. Boston Scientific Corporation Company Information Table 77. Boston Scientific Corporation Business Overview Table 78. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 80. Boston Scientific Corporation Recent Development Table 81. St. Jude Medical Company Information Table 82. St. Jude Medical Business Overview Table 83. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 85. St. Jude Medical Recent Development Table 86. Synapse Biomedical Company Information Table 87. Synapse Biomedical Business Overview Table 88. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 90. Synapse Biomedical Recent Development Table 91. Nevro Corporation Company Information Table 92. Nevro Corporation Business Overview Table 93. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 95. Nevro Corporation Recent Development Table 96. Neuropace Company Information Table 97. Neuropace Business Overview Table 98. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 100. Neuropace Recent Development Table 101. Cyberonics Company Information Table 102. Cyberonics Business Overview Table 103. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 105. Cyberonics Recent Development Table 106. Autonomic Technologies Company Information Table 107. Autonomic Technologies Business Overview Table 108. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 110. Autonomic Technologies Recent Development Table 111. Avery Biomedical Company Information Table 112. Avery Biomedical Business Overview Table 113. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 115. Avery Biomedical Recent Development Table 116. Greatbatch Medical Company Information Table 117. Greatbatch Medical Business Overview Table 118. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 120. Greatbatch Medical Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Neuromodulation Devices and Implantable Infusion Pumps Distributors List Table 124. Neuromodulation Devices and Implantable Infusion Pumps Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Image Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2021-2032) & (Unit) Figure 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Neuromodulation Devices and Implantable Infusion Pumps Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Spinal Cord Stimulation Image Figure 10. Deep Brain Stimulation Image Figure 11. Sacral Nerve Stimulation Image Figure 12. Vagal Nerve Stimulation Image Figure 13. Gastric Stimulation Image Figure 14. Transcranial Magnetic Stimulation Image Figure 15. Transcutaneous Electrical Stimulation Image Figure 16. Other Image Figure 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2021 VS 2025 VS 2032) & (Unit) Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share 2021 VS 2025 VS 2032 Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Type (2021-2032) Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type (2021-2032) Figure 23. Parkinson's Disease Image Figure 24. Epilepsy Image Figure 25. Pain Image Figure 26. Other Image Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2021 VS 2025 VS 2032) & (Unit) Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Application (2021-2032) Figure 30. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application (2021-2032) Figure 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032 (Unit) Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032) & (US$ Million) Figure 38. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032) & (US$ Million) Figure 44. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Neuromodulation Devices and Implantable Infusion Pumps Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Neuromodulation Devices and Implantable Infusion Pumps Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Vagal Nerve Stimulation
  • Gastric Stimulation
  • Transcranial Magnetic Stimulation
  • Transcutaneous Electrical Stimulation
  • Other
Applications
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Other
Companies covered
  • Medtronic
  • Boston Scientific Corporation
  • St. Jude Medical
  • Synapse Biomedical
  • Nevro Corporation
  • Neuropace
  • Cyberonics
  • Autonomic Technologies
  • Avery Biomedical
  • Greatbatch Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032)
  4. 1.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume (2021-2032)
  5. 1.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
  1. 2.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
  2. 2.2 Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers
  3. 2.3 Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges
  4. 2.4 Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints
3 Neuromodulation Devices and Implantable Infusion Pumps Market by Company
  1. 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Company Revenue Ranking in 2025
  2. 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Company (2021-2026)
  3. 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Company (2021-2026)
  4. 3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Company (2021-2026)
  5. 3.5 Global Neuromodulation Devices and Implantable Infusion Pumps Company Ranking (2024-2026)
  6. 3.6 Global Neuromodulation Devices and Implantable Infusion Pumps Company Manufacturing Base and Headquarters
  7. 3.7 Global Neuromodulation Devices and Implantable Infusion Pumps Company Product Type and Application
  8. 3.8 Global Neuromodulation Devices and Implantable Infusion Pumps Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neuromodulation Devices and Implantable Infusion Pumps Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neuromodulation Devices and Implantable Infusion Pumps Market by Type
  1. 4.1 Neuromodulation Devices and Implantable Infusion Pumps Type Introduction
  2. 4.1.1 Spinal Cord Stimulation
  3. 4.1.2 Deep Brain Stimulation
  4. 4.1.3 Sacral Nerve Stimulation
  5. 4.1.4 Vagal Nerve Stimulation
  6. 4.1.5 Gastric Stimulation
  7. 4.1.6 Transcranial Magnetic Stimulation
  8. 4.1.7 Transcutaneous Electrical Stimulation
  9. 4.1.8 Other
  10. 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type
  11. 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Type (2021-2032)
  13. 4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Type (2021-2032)
  14. 4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type
  15. 4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Type (2021-2032)
  17. 4.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type (2021-2032)
5 Neuromodulation Devices and Implantable Infusion Pumps Market by Application
  1. 5.1 Neuromodulation Devices and Implantable Infusion Pumps Application Introduction
  2. 5.1.1 Parkinson's Disease
  3. 5.1.2 Epilepsy
  4. 5.1.3 Pain
  5. 5.1.4 Other
  6. 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application
  7. 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application
  11. 5.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Application (2021-2032)
  13. 5.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application (2021-2032)
6 Neuromodulation Devices and Implantable Infusion Pumps Regional Sales and Value Analysis
  1. 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2032)
  3. 6.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021-2026
  4. 6.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2027-2032)
  5. 6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Region (2027-2032)
  9. 6.5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032)
  12. 6.6.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032)
  15. 6.7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032)
  21. 6.9.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Country, 2025 VS 2032
7 Neuromodulation Devices and Implantable Infusion Pumps Country-level Sales and Value Analysis
  1. 7.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2032)
  4. 7.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026)
  5. 7.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032)
  6. 7.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific Corporation
  8. 8.2.1 Boston Scientific Corporation Company Information
  9. 8.2.2 Boston Scientific Corporation Business Overview
  10. 8.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  12. 8.2.5 Boston Scientific Corporation Recent Developments
  13. 8.3 St. Jude Medical
  14. 8.3.1 St. Jude Medical Company Information
  15. 8.3.2 St. Jude Medical Business Overview
  16. 8.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  18. 8.3.5 St. Jude Medical Recent Developments
  19. 8.4 Synapse Biomedical
  20. 8.4.1 Synapse Biomedical Company Information
  21. 8.4.2 Synapse Biomedical Business Overview
  22. 8.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  24. 8.4.5 Synapse Biomedical Recent Developments
  25. 8.5 Nevro Corporation
  26. 8.5.1 Nevro Corporation Company Information
  27. 8.5.2 Nevro Corporation Business Overview
  28. 8.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  30. 8.5.5 Nevro Corporation Recent Developments
  31. 8.6 Neuropace
  32. 8.6.1 Neuropace Company Information
  33. 8.6.2 Neuropace Business Overview
  34. 8.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  36. 8.6.5 Neuropace Recent Developments
  37. 8.7 Cyberonics
  38. 8.7.1 Cyberonics Company Information
  39. 8.7.2 Cyberonics Business Overview
  40. 8.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  42. 8.7.5 Cyberonics Recent Developments
  43. 8.8 Autonomic Technologies
  44. 8.8.1 Autonomic Technologies Company Information
  45. 8.8.2 Autonomic Technologies Business Overview
  46. 8.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  48. 8.8.5 Autonomic Technologies Recent Developments
  49. 8.9 Avery Biomedical
  50. 8.9.1 Avery Biomedical Company Information
  51. 8.9.2 Avery Biomedical Business Overview
  52. 8.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  54. 8.9.5 Avery Biomedical Recent Developments
  55. 8.10 Greatbatch Medical
  56. 8.10.1 Greatbatch Medical Company Information
  57. 8.10.2 Greatbatch Medical Business Overview
  58. 8.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  60. 8.10.5 Greatbatch Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
  2. 9.1.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neuromodulation Devices and Implantable Infusion Pumps Sales Mode & Process
  6. 9.2 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
  9. 9.2.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst